RESUMO
BACKGROUND: Viruses are the leading cause of acute gastroenteritis in children worldwide. Understanding of the occurrence and genetic diversity of these viruses can help to prevent infections. OBJECTIVES: The present study describes the presence, genetic diversity and possible recombination of five enteric viruses in children with gastroenteritis in Southwestern Nigeria. STUDY DESIGN: From August 2012 to December 2013, stool samples and sociodemographic data of 103 diarrheic children <5 years were collected to detect and characterize rotavirus A, norovirus, human astrovirus, aichivirus and sapovirus using PCR techniques followed by sequencing and phylogenetic analyses. RESULTS: At least one virus was identified in 58.3% (60/103) of the stool samples. Rotavirus, norovirus and astrovirus were detected in 39.8% (41/103), 10.7% (11/103), and 6.8% (7/103) respectively. Notably, aichivirus was detected for the first time in Nigeria (1/103; 0.97%). Sapovirus was not detected in the study. Co-infections with rotavirus were observed in eight samples either with norovirus or astrovirus or aichivirus. Phylogenetic analyses of different genome regions of norovirus positive samples provided indication for recombinant norovirus strains. A novel astrovirus strain closely related to canine astrovirus was identified and further characterized for the first time. CONCLUSIONS: Viruses are the common cause of acute gastroenteritis in Nigerian infants with rotavirus as most frequently detected pathogen. New norovirus recombinants and a not yet detected zoonotic astrovirus were circulating in Southwestern Nigeria, providing new information about emerging and unusual strains of viruses causing diarrhea.
Assuntos
Infecções por Astroviridae/epidemiologia , Astroviridae/classificação , Infecções por Caliciviridae/epidemiologia , Gastroenterite/epidemiologia , Kobuvirus/classificação , Norovirus/classificação , Animais , Astroviridae/isolamento & purificação , Pré-Escolar , Diarreia/virologia , Fezes/virologia , Feminino , Gastroenterite/virologia , Variação Genética , Humanos , Lactente , Recém-Nascido , Kobuvirus/isolamento & purificação , Masculino , Nigéria/epidemiologia , Norovirus/isolamento & purificação , Filogenia , Infecções por Picornaviridae/epidemiologia , RNA Viral/genética , Vírus Reordenados/classificação , Rotavirus/genética , Rotavirus/isolamento & purificação , Zoonoses/virologiaRESUMO
Since early November 2016, the number of laboratory-confirmed norovirus infections reported in Germany has been increasing steeply. Here, we report the detection and genetic characterisation of an emerging norovirus recombinant, GII.P16-GII.2. This strain was frequently identified as the cause of sporadic cases as well as outbreaks in nine federal states of Germany. Our findings suggest that the emergence of GII.P16-GII.2 contributed to rising case numbers of norovirus gastroenteritis in Germany.
Assuntos
Infecções por Caliciviridae/epidemiologia , Surtos de Doenças , Gastroenterite/virologia , Genótipo , Norovirus/classificação , Norovirus/genética , Infecções por Caliciviridae/virologia , Criança , Pré-Escolar , Diarreia/epidemiologia , Diarreia/virologia , Notificação de Doenças/estatística & dados numéricos , Gastroenterite/epidemiologia , Variação Genética , Alemanha/epidemiologia , Humanos , Lactente , Norovirus/isolamento & purificação , Filogenia , RNA Viral/genética , Estações do Ano , Análise de Sequência de DNARESUMO
We analysed data on laboratory or epidemiologically confirmed cases (n = 856,539) and on outbreaks (n = 31,644) notified during week 31 (2001) to week 30 (2009), and performed molecular typing of specimens from 665 outbreaks. We aimed at identifying demographic and molecular characteristics to inform on potential additional approaches to prevent disease spread in the population. The mean incidence by norovirus season (week 31 in one year to week 30 in the following year) was 130 (range 19-300) cases/100,000 population and was highest in persons aged <5 years (430/100,000) and ≥ 75 years (593/100,000). The proportion hospitalized in community-acquired cases was 8-19% per season. The mean norovirus-associated mortality was 0.05/100,000 per season and 0.5/100,000 in the ≥ 75 years age group. Most outbreaks with known setting (75%) occurred in hospitals (32%), nursing homes (28%), households (24%) and childcare facilities (10%). GII strains dominated in the outbreak specimens. GII.4 strains were found in 82% of nursing home outbreaks, 85% of hospital outbreaks, and 33% of childcare facility and school outbreaks. Cases in younger individuals were notified earlier during the season than adult cases, and outbreaks in childcare facilities and schools preceded those in nursing/residential homes, hospitals and private households. We suggest future studies to investigate more closely potential transmission patterns between children and adults.
Assuntos
Infecções por Caliciviridae/epidemiologia , Surtos de Doenças , Gastroenterite/epidemiologia , Norovirus/isolamento & purificação , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Infecções por Caliciviridae/virologia , Criança , Pré-Escolar , Estudos de Coortes , Feminino , Gastroenterite/virologia , Alemanha/epidemiologia , Hospitalização , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Norovirus/genética , Vigilância em Saúde PúblicaRESUMO
Recently, the disappearance of oligoclonal bands (OCBs) from the cerebrospinal fluid (CSF) of a few natalizumab-treated patients with multiple sclerosis (MS) has been reported. This is interesting since CSF-restricted OCB are believed to persist in MS. We pooled CSF data from 14 MS centers to obtain an adequate sample size for investigating the suspected changes in central nervous system (CNS)-restricted humoral immune activities in the context of natalizumab therapy. In a retrospective chart analysis, CSF parameters of blood-CSF barrier integrity and intrathecal IgG production from 73 natalizumab-treated MS patients requiring a diagnostic puncture for exclusion of progressive multifocal leukoencephalopathy were compared with CSF data obtained earlier in the course of disease before natalizumab therapy. At the time of repeat lumbar puncture, local IgG production (according to Reibergram) was significantly reduced (p < 0.0001) and OCB had disappeared in 16% of the patients. We therefore conclude that natalizumab therapy interferes with intrathecal antibody production at least in a significant number of patients.